0 patents currently held, every record listed here
4 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
This portfolio holds none of the 4 US patents in force on its record. from the record
Of the 4 now held by other companies, 4 name CV Biomanufacturing LLC as their current owner. Each row says so.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
none
Next term end
When these terms end
Each bar runs from grant to computed term end. 2019 to 2037.
US 10,238,698
Biomarkers and Combination Therapies Using Oncolytic Virus and Immunomodulation
Jan 25, 2033
US 11,065,285
Biomarkers and Combination Therapies Using Oncolytic Virus and Immunomodulation
no later than Jan 25, 2033
20232027203120352037
A dotted end marks a recorded terminal disclaimer this site has not resolved: the term can only be shorter than the bar, never longer.
3 pending applications: term is not computable until grant.Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
None of the currently held patents qualifies as notable.
Formerly held, still cited
Notable
Ends Jan 2033 · High confidence
The most cited patent in this portfolio, cited by 26 later US patents, top 10% of utility patents granted in 2019 in our data. Protection runs to 2033.
now held by CV Biomanufacturing, LLC
Also notable
Ends Sep 2037 · High confidence
Cited by 11 later US patents, top 25% of utility patents granted in 2021 in our data. Protection runs to 2037.
now held by CV Biomanufacturing, LLC
Also notable
Ends no later than Nov 2037 · Medium confidence
The newest of the three, granted 2021. It anchors the portfolio to 2037, later than anything else here. A terminal disclaimer is on file and its reference is not resolved, so no cap is applied and the date may move earlier, never later.
now held by CV Biomanufacturing, LLC
Fee deadlines
No maintenance fee falls due on this company's record before Nov 10, 2027.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first.
Also on record: 4 patents in force now held by others · 1 patent ended · 3 applications pending · 9 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
2 terminal disclaimers are on file with no resolved reference. No cap is applied and none is guessed